Popular on Rezul
- Houston Market Report Q3 2026 | Industrial Distribution - 298
- Instant DSCR Term Sheet Now Available in ChatGPT for Real Estate Investors - 298
- Wappler Capital Expands Investment Platform Into Georgia - 293
- ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 287
- Cays Realty Launches AI-Powered South Florida Property Search Platform - 255
- Pulte announces Canopy Cove, Pulte's first-ever townhome community in St. Johns County - 242
- CompStak Launches Agent Connect, an MCP Server for Verified Commercial Real Estate Data - 240
- The Enclave at Winslow Fulfills an Important Role in South Jersey's Housing Market - 222
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry - 211
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event - 203
Similar on Rezul
- Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
- Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
- Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
- Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
- HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
Perch Publishes Open Test Set That Catches AI Scribes Inventing Drug Names
Rezul News/10748740
The public test set puts Perch's own results next to a commercial veterinary AI scribe's, on the same clips, including a case where the other product charted a drug that does not exist.
NEW YORK - Rezul -- Perch, the veterinary AI scribe built by Talcoe LLC, today published an open test set against itself, built to catch one specific failure: an AI scribe writing a medication into a chart that nobody said. The test set includes Perch's own results next to a miss from a commercial veterinary AI scribe run on the same clips.
The test set holds 70 short clinical dictations: 45 ordinary cases and 25 traps written to bait a false drug name. The dictations carry 84 drug mentions. Talcoe ran the same 70 clips through Perch and through a commercial veterinary AI scribe.
In one clip, the other product in the test charted Roflexacin, a drug that does not exist, next to the Baytril that was actually dictated.
More on Rezul News
An earlier Perch build had its own miss, on a separate test set: it charted Zycortal, a real but wrong drug, on one of its own trap clips. The build running today declines to chart anything on that clip rather than guess. The other product's repair layer also recovered atenolol from a badly garbled dictation, on a clip where one of Perch's two speech configurations missed it.
Across the full run, Perch invented zero drug names on its side of the clips.
One limit applies. The audio is synthetic text to speech voices, one voice per clip, not a real clinician in a real exam room. This is Perch's own test, and real speech runs harder than synthetic speech. Talcoe is publishing it as a reproducible, shared test set, not an accuracy claim about any product.
The clips, written dictations and scoring method are posted at https://github.com/perchvet/perch-trapset. A longer account of the run is posted at https://perch.talcoe.com/news/invented-drug-names-test.
More on Rezul News
"We built this test to check whether an AI scribe can put a drug into a medical record that nobody said, and we ran it on our own product first," said Mohammed Usama, cofounder of Talcoe LLC. "The clips, the written dictations, and the scoring method are all public, so a vet or a reporter can check the finding rather than take our word for it."
About Perch: Perch is a veterinary AI scribe built by a two person team at Talcoe LLC in New York. A vet talks through a visit, and Perch drafts the note in SOAP, DAP or BIRP format while the vet is still speaking. It runs in the browser, works alongside AVImark, and is free to start with a 30 day pilot.
The test set holds 70 short clinical dictations: 45 ordinary cases and 25 traps written to bait a false drug name. The dictations carry 84 drug mentions. Talcoe ran the same 70 clips through Perch and through a commercial veterinary AI scribe.
In one clip, the other product in the test charted Roflexacin, a drug that does not exist, next to the Baytril that was actually dictated.
More on Rezul News
- Denver Real Estate Meetup Brings Investors Together Every Month in LoDo
- Gwinnett County Celebrates 21 New Homeowners and Power of Partnership to Expand Homeownership
- WOWX labs Closes US$10 Million Founder-Led Growth Financing as WOWX.market Enters Scale Phase
- Ironrock Commercial Construction Expands Central Florida Offerings with Expert Site Development Commercial Services
- BESTBUYSTORE opens its dropshipping model to independent merchants
An earlier Perch build had its own miss, on a separate test set: it charted Zycortal, a real but wrong drug, on one of its own trap clips. The build running today declines to chart anything on that clip rather than guess. The other product's repair layer also recovered atenolol from a badly garbled dictation, on a clip where one of Perch's two speech configurations missed it.
Across the full run, Perch invented zero drug names on its side of the clips.
One limit applies. The audio is synthetic text to speech voices, one voice per clip, not a real clinician in a real exam room. This is Perch's own test, and real speech runs harder than synthetic speech. Talcoe is publishing it as a reproducible, shared test set, not an accuracy claim about any product.
The clips, written dictations and scoring method are posted at https://github.com/perchvet/perch-trapset. A longer account of the run is posted at https://perch.talcoe.com/news/invented-drug-names-test.
More on Rezul News
- America's Hometown Thanksgiving Parade in Plymouth, MA, on Saturday, November 21, 2026
- Navigating a Changing Market: How AIX Group Is Responding to a Challenging Year
- 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST)
- Wave Helicopters Takes FLIBS 2026 to New Heights
- Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature
"We built this test to check whether an AI scribe can put a drug into a medical record that nobody said, and we ran it on our own product first," said Mohammed Usama, cofounder of Talcoe LLC. "The clips, the written dictations, and the scoring method are all public, so a vet or a reporter can check the finding rather than take our word for it."
About Perch: Perch is a veterinary AI scribe built by a two person team at Talcoe LLC in New York. A vet talks through a visit, and Perch drafts the note in SOAP, DAP or BIRP format while the vet is still speaking. It runs in the browser, works alongside AVImark, and is free to start with a 30 day pilot.
Source: Talcoe LLC
0 Comments
Latest on Rezul News
- Elmington Residential Acquires 260-Unit Workforce Housing Community in Atlanta, GA
- The Appraisal On Your Home Is About To Look Different: What Florida Sellers Should Know Before Nov 2
- ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection
- New Book Helps Real Estate Agents Build Careers That Last
- National Literacy and Workforce Readiness Crisis Sparks New Program Launching in Birmingham
- New England Consulting Partners Celebrates 25 Years of Turnaround Management Solutions
- RAS AP Consulting Releases Educational Resource to Help Organizations Prepare for IRS FIRE-to-IRIS Transition
- Roots, Rhythm & Joy Invites Neighbors to Find Community Through Music
- The Housing "Market" is Not Everybody Shopping in the Same Store
- Van Matre Construction Elevates Foundation Repair Standards in Lafayette
- Austin Texas Real Estate Market: Home Sales Fell 14.8% in September, Far Faster Than the U.S
- Market Report Q3 2026| Houston Citywide Office
- Former Goddard Enterprises Managing Director Anthony Ali Joins STS Capital Partners as Managing Director and Partner
- 4th Qtr. 2026 Brevard County, Florida Rental Property Trends
- Real Estate Lucy Lety Explains Why Rising Home Prices and Fewer Sales Require a Smarter Prici
- Heritage at Manalapan Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Homes
- Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
- KeysCaribbean Announces Temporarily Reduced Rates At Village at Hawks Cay Villas
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee